 Source: Daniel Patrick Martin Shutterstock.com MindMed NASDAQ: MNMD stock is in the news Wednesday after the psychedelic medicine company regained Nasdaq compliance. According to a press release from the company, it has satisfied the Nasdaqs minimum bid price listing requirement. 